-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Breakthrough Therapy Designation to Oculis Holding AG's Privosegtor for Optic Neuritis

路透·01/06/2026 09:00:12

登錄查看新聞詳情